Spots Global Cancer Trial Database for indomethacin
Every month we try and update this database with for indomethacin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase I Platinum Based Chemotherapy Plus Indomethacin | NCT01719926 | Colorectal Neop... Esophageal Neop... Ovarian Neoplas... | Indomethacin | 18 Years - | UMC Utrecht | |
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 | NCT03267680 | Cervical Squamo... Vulvar High Gra... | Cyclophosphamid... Indomethacin IRX-2 Laboratory Biom... Multivitamin Omeprazole Placebo Therapeutic Con... | 25 Years - | University of Southern California | |
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer | NCT00210470 | Squamous Cell C... | IRX-2 Cyclophosphamid... Indomethacin Zinc Omeprazole | 18 Years - 80 Years | Brooklyn ImmunoTherapeutics, LLC | |
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | NCT00002796 | Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | fluorouracil sodium phenylbu... indomethacin recombinant int... | - | National Cancer Institute (NCI) | |
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity | NCT01265849 | Squamous Cell C... Squamous Cell C... | LI Cyclophosphamid... Indomethacin Zinc Surgery Cisplatin Radiotherapy | 18 Years - | CEL-SCI Corporation | |
Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma | NCT00002535 | Melanoma (Skin) | aldesleukin lymphokine-acti... therapeutic tum... cyclophosphamid... indomethacin | 17 Years - | National Cancer Institute (NCI) | |
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | NCT00002796 | Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | fluorouracil sodium phenylbu... indomethacin recombinant int... | - | National Cancer Institute (NCI) | |
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity | NCT01265849 | Squamous Cell C... Squamous Cell C... | LI Cyclophosphamid... Indomethacin Zinc Surgery Cisplatin Radiotherapy | 18 Years - | CEL-SCI Corporation | |
Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma | NCT00002535 | Melanoma (Skin) | aldesleukin lymphokine-acti... therapeutic tum... cyclophosphamid... indomethacin | 17 Years - | National Cancer Institute (NCI) | |
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer | NCT00210470 | Squamous Cell C... | IRX-2 Cyclophosphamid... Indomethacin Zinc Omeprazole | 18 Years - 80 Years | Brooklyn ImmunoTherapeutics, LLC | |
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) | NCT02950259 | Breast Neoplasm Breast Neoplasm... Triple Negative... | Cyclophosphamid... Indomethacin Omeprazole Multivitamin | - | Providence Health & Services | |
Phase I Platinum Based Chemotherapy Plus Indomethacin | NCT01719926 | Colorectal Neop... Esophageal Neop... Ovarian Neoplas... | Indomethacin | 18 Years - | UMC Utrecht | |
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer | NCT02935205 | Metastatic Pros... Recurrent Prost... Stage IV Prosta... | Enzalutamide Indomethacin | 19 Years - | University of California, Davis | |
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 | NCT03267680 | Cervical Squamo... Vulvar High Gra... | Cyclophosphamid... Indomethacin IRX-2 Laboratory Biom... Multivitamin Omeprazole Placebo Therapeutic Con... | 25 Years - | University of Southern California | |
Phase I Platinum Based Chemotherapy Plus Indomethacin | NCT01719926 | Colorectal Neop... Esophageal Neop... Ovarian Neoplas... | Indomethacin | 18 Years - | UMC Utrecht | |
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) | NCT02950259 | Breast Neoplasm Breast Neoplasm... Triple Negative... | Cyclophosphamid... Indomethacin Omeprazole Multivitamin | - | Providence Health & Services |